nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0302	0.0402	CbGbCtD
Levomilnacipran—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0302	0.0402	CbGbCtD
Levomilnacipran—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0298	0.0396	CbGbCtD
Levomilnacipran—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.028	0.0373	CbGbCtD
Levomilnacipran—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0253	0.0337	CbGbCtD
Levomilnacipran—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0253	0.0337	CbGbCtD
Levomilnacipran—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0229	0.0304	CbGbCtD
Levomilnacipran—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0229	0.0304	CbGbCtD
Levomilnacipran—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0226	0.0301	CbGbCtD
Levomilnacipran—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0226	0.0301	CbGbCtD
Levomilnacipran—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0219	0.0292	CbGbCtD
Levomilnacipran—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0219	0.0291	CbGbCtD
Levomilnacipran—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0213	0.0283	CbGbCtD
Levomilnacipran—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0213	0.0283	CbGbCtD
Levomilnacipran—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0212	0.0282	CbGbCtD
Levomilnacipran—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0204	0.0272	CbGbCtD
Levomilnacipran—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0193	0.0256	CbGbCtD
Levomilnacipran—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0193	0.0256	CbGbCtD
Levomilnacipran—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0192	0.0255	CbGbCtD
Levomilnacipran—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0192	0.0255	CbGbCtD
Levomilnacipran—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0184	0.0245	CbGbCtD
Levomilnacipran—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0176	0.0235	CbGbCtD
Levomilnacipran—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0171	0.0228	CbGbCtD
Levomilnacipran—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0166	0.0221	CbGbCtD
Levomilnacipran—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0161	0.0215	CbGbCtD
Levomilnacipran—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0155	0.0206	CbGbCtD
Levomilnacipran—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0155	0.0206	CbGbCtD
Levomilnacipran—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0148	0.0198	CbGbCtD
Levomilnacipran—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0146	0.0194	CbGbCtD
Levomilnacipran—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0146	0.0194	CbGbCtD
Levomilnacipran—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0144	0.0192	CbGbCtD
Levomilnacipran—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0135	0.018	CbGbCtD
Levomilnacipran—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0135	0.018	CbGbCtD
Levomilnacipran—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0122	0.0163	CbGbCtD
Levomilnacipran—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0122	0.0163	CbGbCtD
Levomilnacipran—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0115	0.0153	CbGbCtD
Levomilnacipran—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0106	0.0141	CbGbCtD
Levomilnacipran—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0103	0.0137	CbGbCtD
Levomilnacipran—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00928	0.0123	CbGbCtD
Levomilnacipran—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00928	0.0123	CbGbCtD
Levomilnacipran—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00889	0.0118	CbGbCtD
Levomilnacipran—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00222	0.0679	CbGeAlD
Levomilnacipran—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.0019	0.0584	CbGeAlD
Levomilnacipran—CYP2J2—skin of body—acquired immunodeficiency syndrome	0.0017	0.052	CbGeAlD
Levomilnacipran—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00158	0.0484	CbGeAlD
Levomilnacipran—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00138	0.0422	CbGeAlD
Levomilnacipran—CYP2J2—spinal cord—acquired immunodeficiency syndrome	0.00125	0.0382	CbGeAlD
Levomilnacipran—CYP2J2—vagina—acquired immunodeficiency syndrome	0.0012	0.0368	CbGeAlD
Levomilnacipran—CYP2J2—lung—acquired immunodeficiency syndrome	0.00113	0.0348	CbGeAlD
Levomilnacipran—CYP2J2—nervous system—acquired immunodeficiency syndrome	0.00105	0.0322	CbGeAlD
Levomilnacipran—CYP2J2—central nervous system—acquired immunodeficiency syndrome	0.00101	0.031	CbGeAlD
Levomilnacipran—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000933	0.0286	CbGeAlD
Levomilnacipran—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000918	0.0281	CbGeAlD
Levomilnacipran—CYP2J2—brain—acquired immunodeficiency syndrome	0.000803	0.0246	CbGeAlD
Levomilnacipran—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000732	0.0224	CbGeAlD
Levomilnacipran—SLC6A4—blood—acquired immunodeficiency syndrome	0.000697	0.0214	CbGeAlD
Levomilnacipran—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000672	0.0206	CbGeAlD
Levomilnacipran—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00066	0.0202	CbGeAlD
Levomilnacipran—SLC6A4—lung—acquired immunodeficiency syndrome	0.000611	0.0187	CbGeAlD
Levomilnacipran—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000607	0.0186	CbGeAlD
Levomilnacipran—CYP2C19—blood—acquired immunodeficiency syndrome	0.000578	0.0177	CbGeAlD
Levomilnacipran—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000566	0.0174	CbGeAlD
Levomilnacipran—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000545	0.0167	CbGeAlD
Levomilnacipran—SLC6A2—lung—acquired immunodeficiency syndrome	0.000538	0.0165	CbGeAlD
Levomilnacipran—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000536	0.0164	CbGeAlD
Levomilnacipran—CYP2C8—blood—acquired immunodeficiency syndrome	0.000504	0.0155	CbGeAlD
Levomilnacipran—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000498	0.0153	CbGeAlD
Levomilnacipran—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00048	0.0147	CbGeAlD
Levomilnacipran—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000468	0.0143	CbGeAlD
Levomilnacipran—SLC6A4—brain—acquired immunodeficiency syndrome	0.000433	0.0133	CbGeAlD
Levomilnacipran—SLC6A2—brain—acquired immunodeficiency syndrome	0.000381	0.0117	CbGeAlD
Levomilnacipran—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000368	0.0113	CbGeAlD
Levomilnacipran—ABCB1—retina—acquired immunodeficiency syndrome	0.000362	0.0111	CbGeAlD
Levomilnacipran—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000359	0.011	CbGeAlD
Levomilnacipran—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000353	0.0108	CbGeAlD
Levomilnacipran—CYP3A4—blood—acquired immunodeficiency syndrome	0.000342	0.0105	CbGeAlD
Levomilnacipran—CYP2D6—blood—acquired immunodeficiency syndrome	0.000336	0.0103	CbGeAlD
Levomilnacipran—CYP2C8—brain—acquired immunodeficiency syndrome	0.000313	0.00959	CbGeAlD
Levomilnacipran—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000277	0.0085	CbGeAlD
Levomilnacipran—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000273	0.00837	CbGeAlD
Levomilnacipran—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000267	0.00818	CbGeAlD
Levomilnacipran—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000263	0.00805	CbGeAlD
Levomilnacipran—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000257	0.00788	CbGeAlD
Levomilnacipran—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000254	0.00778	CbGeAlD
Levomilnacipran—ABCB1—blood—acquired immunodeficiency syndrome	0.000242	0.00741	CbGeAlD
Levomilnacipran—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000234	0.00717	CbGeAlD
Levomilnacipran—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000233	0.00714	CbGeAlD
Levomilnacipran—ABCB1—vagina—acquired immunodeficiency syndrome	0.000224	0.00687	CbGeAlD
Levomilnacipran—ABCB1—lung—acquired immunodeficiency syndrome	0.000212	0.0065	CbGeAlD
Levomilnacipran—CYP2D6—brain—acquired immunodeficiency syndrome	0.000209	0.00639	CbGeAlD
Levomilnacipran—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000197	0.00091	CcSEcCtD
Levomilnacipran—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.00091	CcSEcCtD
Levomilnacipran—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000909	CcSEcCtD
Levomilnacipran—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000196	0.00602	CbGeAlD
Levomilnacipran—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000196	0.000908	CcSEcCtD
Levomilnacipran—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.000905	CcSEcCtD
Levomilnacipran—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000904	CcSEcCtD
Levomilnacipran—Rash—Didanosine—acquired immunodeficiency syndrome	0.000195	0.000902	CcSEcCtD
Levomilnacipran—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000902	CcSEcCtD
Levomilnacipran—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000902	CcSEcCtD
Levomilnacipran—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000195	0.000902	CcSEcCtD
Levomilnacipran—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000195	0.000902	CcSEcCtD
Levomilnacipran—Headache—Didanosine—acquired immunodeficiency syndrome	0.000194	0.000897	CcSEcCtD
Levomilnacipran—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000895	CcSEcCtD
Levomilnacipran—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.000894	CcSEcCtD
Levomilnacipran—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000893	CcSEcCtD
Levomilnacipran—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000893	CcSEcCtD
Levomilnacipran—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000193	0.000892	CcSEcCtD
Levomilnacipran—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000891	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000889	CcSEcCtD
Levomilnacipran—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000888	CcSEcCtD
Levomilnacipran—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000888	CcSEcCtD
Levomilnacipran—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000886	CcSEcCtD
Levomilnacipran—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000886	CcSEcCtD
Levomilnacipran—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000885	CcSEcCtD
Levomilnacipran—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000884	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000883	CcSEcCtD
Levomilnacipran—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000882	CcSEcCtD
Levomilnacipran—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.000882	CcSEcCtD
Levomilnacipran—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00019	0.000881	CcSEcCtD
Levomilnacipran—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00019	0.000879	CcSEcCtD
Levomilnacipran—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00019	0.000878	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000878	CcSEcCtD
Levomilnacipran—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000876	CcSEcCtD
Levomilnacipran—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000189	0.00579	CbGeAlD
Levomilnacipran—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000873	CcSEcCtD
Levomilnacipran—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000873	CcSEcCtD
Levomilnacipran—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.00087	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00087	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000867	CcSEcCtD
Levomilnacipran—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000187	0.000866	CcSEcCtD
Levomilnacipran—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000866	CcSEcCtD
Levomilnacipran—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000866	CcSEcCtD
Levomilnacipran—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000859	CcSEcCtD
Levomilnacipran—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000858	CcSEcCtD
Levomilnacipran—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000858	CcSEcCtD
Levomilnacipran—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000858	CcSEcCtD
Levomilnacipran—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000857	CcSEcCtD
Levomilnacipran—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000855	CcSEcCtD
Levomilnacipran—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.000854	CcSEcCtD
Levomilnacipran—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.000854	CcSEcCtD
Levomilnacipran—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000184	0.000853	CcSEcCtD
Levomilnacipran—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000852	CcSEcCtD
Levomilnacipran—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000184	0.00085	CcSEcCtD
Levomilnacipran—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000184	0.00085	CcSEcCtD
Levomilnacipran—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000848	CcSEcCtD
Levomilnacipran—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000847	CcSEcCtD
Levomilnacipran—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.000846	CcSEcCtD
Levomilnacipran—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000846	CcSEcCtD
Levomilnacipran—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000844	CcSEcCtD
Levomilnacipran—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000843	CcSEcCtD
Levomilnacipran—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.00084	CcSEcCtD
Levomilnacipran—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000181	0.000838	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000837	CcSEcCtD
Levomilnacipran—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000835	CcSEcCtD
Levomilnacipran—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00083	CcSEcCtD
Levomilnacipran—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000826	CcSEcCtD
Levomilnacipran—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000825	CcSEcCtD
Levomilnacipran—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000824	CcSEcCtD
Levomilnacipran—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.000824	CcSEcCtD
Levomilnacipran—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000823	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000822	CcSEcCtD
Levomilnacipran—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000178	0.000822	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000821	CcSEcCtD
Levomilnacipran—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000821	CcSEcCtD
Levomilnacipran—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000819	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000819	CcSEcCtD
Levomilnacipran—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000818	CcSEcCtD
Levomilnacipran—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000177	0.000818	CcSEcCtD
Levomilnacipran—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000818	CcSEcCtD
Levomilnacipran—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000816	CcSEcCtD
Levomilnacipran—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000815	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000812	CcSEcCtD
Levomilnacipran—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000812	CcSEcCtD
Levomilnacipran—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000175	0.000811	CcSEcCtD
Levomilnacipran—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000175	0.000811	CcSEcCtD
Levomilnacipran—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.00081	CcSEcCtD
Levomilnacipran—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000175	0.000809	CcSEcCtD
Levomilnacipran—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000807	CcSEcCtD
Levomilnacipran—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000174	0.000806	CcSEcCtD
Levomilnacipran—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000804	CcSEcCtD
Levomilnacipran—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000803	CcSEcCtD
Levomilnacipran—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000801	CcSEcCtD
Levomilnacipran—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.0008	CcSEcCtD
Levomilnacipran—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000799	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000799	CcSEcCtD
Levomilnacipran—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000798	CcSEcCtD
Levomilnacipran—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000795	CcSEcCtD
Levomilnacipran—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000794	CcSEcCtD
Levomilnacipran—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000794	CcSEcCtD
Levomilnacipran—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000793	CcSEcCtD
Levomilnacipran—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000171	0.000792	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000791	CcSEcCtD
Levomilnacipran—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000171	0.00079	CcSEcCtD
Levomilnacipran—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000789	CcSEcCtD
Levomilnacipran—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000787	CcSEcCtD
Levomilnacipran—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00017	0.000786	CcSEcCtD
Levomilnacipran—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00017	0.000785	CcSEcCtD
Levomilnacipran—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000785	CcSEcCtD
Levomilnacipran—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000785	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000784	CcSEcCtD
Levomilnacipran—Rash—Stavudine—acquired immunodeficiency syndrome	0.000169	0.000783	CcSEcCtD
Levomilnacipran—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000783	CcSEcCtD
Levomilnacipran—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000169	0.000783	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000781	CcSEcCtD
Levomilnacipran—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000169	0.000781	CcSEcCtD
Levomilnacipran—Headache—Stavudine—acquired immunodeficiency syndrome	0.000168	0.000778	CcSEcCtD
Levomilnacipran—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000168	0.000778	CcSEcCtD
Levomilnacipran—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000776	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000776	CcSEcCtD
Levomilnacipran—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.000775	CcSEcCtD
Levomilnacipran—Rash—Abacavir—acquired immunodeficiency syndrome	0.000167	0.000772	CcSEcCtD
Levomilnacipran—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000167	0.000771	CcSEcCtD
Levomilnacipran—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.00077	CcSEcCtD
Levomilnacipran—Headache—Abacavir—acquired immunodeficiency syndrome	0.000166	0.000767	CcSEcCtD
Levomilnacipran—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000766	CcSEcCtD
Levomilnacipran—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.000764	CcSEcCtD
Levomilnacipran—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000764	CcSEcCtD
Levomilnacipran—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000759	CcSEcCtD
Levomilnacipran—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000759	CcSEcCtD
Levomilnacipran—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000756	CcSEcCtD
Levomilnacipran—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000755	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000755	CcSEcCtD
Levomilnacipran—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000754	CcSEcCtD
Levomilnacipran—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000754	CcSEcCtD
Levomilnacipran—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00075	CcSEcCtD
Levomilnacipran—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00075	CcSEcCtD
Levomilnacipran—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000749	CcSEcCtD
Levomilnacipran—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000749	CcSEcCtD
Levomilnacipran—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000746	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000745	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000742	CcSEcCtD
Levomilnacipran—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.00074	CcSEcCtD
Levomilnacipran—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00016	0.00074	CcSEcCtD
Levomilnacipran—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000739	CcSEcCtD
Levomilnacipran—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000739	CcSEcCtD
Levomilnacipran—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000159	0.000738	CcSEcCtD
Levomilnacipran—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000735	CcSEcCtD
Levomilnacipran—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000731	CcSEcCtD
Levomilnacipran—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00073	CcSEcCtD
Levomilnacipran—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000157	0.000727	CcSEcCtD
Levomilnacipran—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000726	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000725	CcSEcCtD
Levomilnacipran—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000724	CcSEcCtD
Levomilnacipran—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000721	CcSEcCtD
Levomilnacipran—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000721	CcSEcCtD
Levomilnacipran—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000721	CcSEcCtD
Levomilnacipran—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.00072	CcSEcCtD
Levomilnacipran—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000718	CcSEcCtD
Levomilnacipran—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000718	CcSEcCtD
Levomilnacipran—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000718	CcSEcCtD
Levomilnacipran—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000718	CcSEcCtD
Levomilnacipran—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000714	CcSEcCtD
Levomilnacipran—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000711	CcSEcCtD
Levomilnacipran—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000711	CcSEcCtD
Levomilnacipran—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000703	CcSEcCtD
Levomilnacipran—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000699	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000698	CcSEcCtD
Levomilnacipran—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000697	CcSEcCtD
Levomilnacipran—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000697	CcSEcCtD
Levomilnacipran—ABCB1—brain—acquired immunodeficiency syndrome	0.00015	0.0046	CbGeAlD
Levomilnacipran—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000692	CcSEcCtD
Levomilnacipran—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000691	CcSEcCtD
Levomilnacipran—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000687	CcSEcCtD
Levomilnacipran—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000687	CcSEcCtD
Levomilnacipran—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000148	0.000687	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000687	CcSEcCtD
Levomilnacipran—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000685	CcSEcCtD
Levomilnacipran—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000681	CcSEcCtD
Levomilnacipran—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000681	CcSEcCtD
Levomilnacipran—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.00068	CcSEcCtD
Levomilnacipran—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000679	CcSEcCtD
Levomilnacipran—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000677	CcSEcCtD
Levomilnacipran—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000671	CcSEcCtD
Levomilnacipran—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000145	0.00444	CbGeAlD
Levomilnacipran—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.00067	CcSEcCtD
Levomilnacipran—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000669	CcSEcCtD
Levomilnacipran—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000667	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000666	CcSEcCtD
Levomilnacipran—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000665	CcSEcCtD
Levomilnacipran—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000664	CcSEcCtD
Levomilnacipran—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000664	CcSEcCtD
Levomilnacipran—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000664	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000661	CcSEcCtD
Levomilnacipran—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000659	CcSEcCtD
Levomilnacipran—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000651	CcSEcCtD
Levomilnacipran—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000649	CcSEcCtD
Levomilnacipran—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000642	CcSEcCtD
Levomilnacipran—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000642	CcSEcCtD
Levomilnacipran—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000642	CcSEcCtD
Levomilnacipran—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000639	CcSEcCtD
Levomilnacipran—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000639	CcSEcCtD
Levomilnacipran—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000138	0.000639	CcSEcCtD
Levomilnacipran—Rash—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000633	CcSEcCtD
Levomilnacipran—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000633	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.00063	CcSEcCtD
Levomilnacipran—Headache—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000629	CcSEcCtD
Levomilnacipran—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000628	CcSEcCtD
Levomilnacipran—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000621	CcSEcCtD
Levomilnacipran—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000619	CcSEcCtD
Levomilnacipran—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000612	CcSEcCtD
Levomilnacipran—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000609	CcSEcCtD
Levomilnacipran—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000609	CcSEcCtD
Levomilnacipran—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000603	CcSEcCtD
Levomilnacipran—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000602	CcSEcCtD
Levomilnacipran—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.0006	CcSEcCtD
Levomilnacipran—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000598	CcSEcCtD
Levomilnacipran—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000598	CcSEcCtD
Levomilnacipran—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000597	CcSEcCtD
Levomilnacipran—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000595	CcSEcCtD
Levomilnacipran—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000595	CcSEcCtD
Levomilnacipran—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000594	CcSEcCtD
Levomilnacipran—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00058	CcSEcCtD
Levomilnacipran—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000577	CcSEcCtD
Levomilnacipran—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000575	CcSEcCtD
Levomilnacipran—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000573	CcSEcCtD
Levomilnacipran—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000572	CcSEcCtD
Levomilnacipran—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000572	CcSEcCtD
Levomilnacipran—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000569	CcSEcCtD
Levomilnacipran—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000568	CcSEcCtD
Levomilnacipran—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000564	CcSEcCtD
Levomilnacipran—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000555	CcSEcCtD
Levomilnacipran—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000553	CcSEcCtD
Levomilnacipran—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000553	CcSEcCtD
Levomilnacipran—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000545	CcSEcCtD
Levomilnacipran—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000539	CcSEcCtD
Levomilnacipran—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000534	CcSEcCtD
Levomilnacipran—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000534	CcSEcCtD
Levomilnacipran—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000529	CcSEcCtD
Levomilnacipran—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000529	CcSEcCtD
Levomilnacipran—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000528	CcSEcCtD
Levomilnacipran—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000526	CcSEcCtD
Levomilnacipran—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000514	CcSEcCtD
Levomilnacipran—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.00051	CcSEcCtD
Levomilnacipran—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00051	CcSEcCtD
Levomilnacipran—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000509	CcSEcCtD
Levomilnacipran—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000506	CcSEcCtD
Levomilnacipran—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000499	CcSEcCtD
Levomilnacipran—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00049	CcSEcCtD
Levomilnacipran—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000486	CcSEcCtD
Levomilnacipran—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000486	CcSEcCtD
Levomilnacipran—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000483	CcSEcCtD
Levomilnacipran—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00048	CcSEcCtD
Levomilnacipran—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.89e-05	0.000458	CcSEcCtD
